175 results
10-K
2021 FY
EX-10.34
VYNT
Vyant Bio, Inc.
Annual report
30 Mar 22
7:27am
10-K
2021 FY
EX-10.25
VYNT
Vyant Bio, Inc.
Annual report
30 Mar 22
7:27am
10-K
2021 FY
EX-10.31
VYNT
Vyant Bio, Inc.
Annual report
30 Mar 22
7:27am
10-K
2021 FY
EX-10.33
VYNT
Vyant Bio, Inc.
Annual report
30 Mar 22
7:27am
10-K
2021 FY
EX-10.34
VYNT
Vyant Bio, Inc.
Annual report
30 Mar 22
7:27am
8-K
EX-10.5
u2cg2
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.1
7jkmiq4ntxppeb06tz2
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.7
mj7f9b7t15 cuos
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.2
5a2m7ib5 pc76sv64
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.4
io0jqa1 tu9z
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.6
ifzbytjx 67ktyi0
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.3
59r837p
5 Apr 21
Report of Independent Registered Public Accounting Firm
5:12pm
8-K
EX-10.2
vcifv
16 Feb 21
Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules
4:51pm
8-K
EX-10.1
xrngukjah6uqs1
16 Feb 21
Cancer Genetics Announces $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules
4:51pm
S-4/A
EX-10.45
fprq6by
8 Feb 21
Registration of securities issued in business combination transactions (amended)
10:46am
S-4/A
EX-10.44
th97e
8 Feb 21
Registration of securities issued in business combination transactions (amended)
10:46am
S-4/A
EX-10.41
haxhq 5he5qa
8 Feb 21
Registration of securities issued in business combination transactions (amended)
10:46am
S-4/A
EX-10.42
cnw3fm29v3s
8 Feb 21
Registration of securities issued in business combination transactions (amended)
10:46am